Publications

Talwar S, I. B. Squire, J. E. Davies, D.B. Barnett, L. L. Ng. Plasma N-Terminal Pro-Brain Natriuretic Peptide in the assessment of left-ventricular systolic dysfunction in a high risk (hospital) population. European Heart Journal 1999; 20: 1736-44.

Hughes D, Talwar S, Squire IB, Davies JE, Ng LL. An Immunoluminometric assay (ILMA) for N-terminal proBNP: development of a test for left ventricular dysfunction. Clinical Science (Colch) 1999; 96: 373-380.

Downie PF, Talwar S, I. B. Squire, J. E. Davies, D.B. Barnett, L. L. Ng. Assessment of the in-vitro stability of N-terminal proBNP: Implications for assessment of Left Ventricular Dysfunction. Clinical Science (Colch) 1999; 97: 255-258.

Talwar S, Downie P.F, Squire IB, Barnett D.B, Davies J.D, Ng L.L. An immunoluminometric assay for Cardiotrophin-1: A newly identified cytokine is present in normal human plasma and is increased in heart failure. Biochem Biophys Res Commun 1999; 261: 567-571

Talwar S, A Siebenhofer, B Williams, LL Ng. Influence of hypertension, left ventricular hypertrophy & left ventricular systolic dysfunction on plasma N-Terminal pro-BNP. Heart 2000; 83: 278-282.

Talwar S; IB Squire; PF Downie ; AM McCullough; MC Campton; JE Davies ; DB Barnett; LL Ng. Profile of plasma N-Terminal proBNP following Acute Myocardial Infarction. European Heart Journal 2000; 21, 1514-1521.

Talwar S, Paul F Downie, Iain B Squire, Joan E Davies, David B Barnett, Leong L Ng. Plasma NT pro BNP and Cardiotrophin-1 are elevated in aortic stenosis. European Journal of Heart Failure 2001; 3(1): 15-19.

Downie PF, Talwar S, Squire IB, Davies JE, Ng LL. Prolonged Stability of Endogenous Cardiotrophin-1 in whole blood. Metabolism 2001; 50(2): 237-240.

Talwar S, Squire IB, Downie PF, O’brien RJ, Davies J.E, Ng LL. Elevated Circulating Plasma Cardiotrophin-1 in heart failure: relationship with parameters of left ventricular systolic dysfunction. Clinical Science (Colch) 2000; 99: 83-88.

S Ghosh, LL Ng, Talwar S, IB Squire, M Galinanes. CT-1 protects the human myocardium from ischaemic injury. Comparison with the first and second window of protection by ischaemic preconditioning. Cardiovascular research 2000; 48: 440-447.

Talwar S, IB Squire, JE Davies, DB Barnett, LL Ng. The effect of valvular regurgitation on plasma CT-1 in patients with normal left ventricular function. European Journal of Heart Failure 2000; 2(4): 387-391.

Talwar S, Squire IB, O’Brien RJ, Downie PF, Davies JE, Ng L.L. Plasma Cardiotrophin-1 Following Acute Myocardial Infarction: Relationship To Left Ventricular Systolic Dysfunction. Clinical Science (Colch) 2002; 102: 9-14.

Talwar S, PF Downie, LL Ng, IB Squire. Towards a blood test for heart failure: the potential use of circulating natriuretic peptides. British Journal of Clinical Pharmacology 2000; 50: 15-20.

Talwar S, Iain B Squire, Paul F Downie , Joan E Davies, David B Barnett , Leong L Ng. Plasma Cardiotrophin-1 and N-Terminal pro-Brain Natriuretic Peptide are elevated in Unstable Angina. Heart 2000; 84: 421-424.

K Jacob, S Talwar, A Copplestone, T G Gilbert, G A Haywood. Plasma Fibrinogen, Antithrombin III, Protein C and D-dimers in patients with chronic atrial fibrillation: Effects of electrical cardioversion in the short and medium term. International Journal of Cardiology (In Press).

Talwar s et al. Disease progression and adverse events in patients listed for elective percutaneous coronary intervention. Postgrad Med J. 2005 Jul;81(957):459-62.

Talwar s et al. Disease progression and adverse events in patients listed for elective percutaneous coronary intervention. Postgrad Med J. 2005 Jul;81(957):459-62.

Percutaneous Coronary Angioplasty in a District General Hospital. Safe and Effective –The Bournemouth Model. Dominic Kelly, Manas Sinha, Rosie Swallow, Terry Levy, Johannes Radvan, Adrian Rozkovec, Suneel Talwar. British Journal of Cardiology 2008;15:244-247.

McKenzie DB, Rao U, Hobson A, Levy T, Talwar S, Swallow R. A novel strategy for managing Clopidogrel-Induced Adverse skin reactions. EuroIntervention 2009 Sep;5(4):470-4

Jokhi PP, Talwar S. Transradial percutaneous coronary intervention for acute myocardial infarction. Journal of the Indian Medical Association 2009;107:598-601.

Jokhi PP, Talwar S. Transradial percutaneous coronary intervention for acute myocardial infarction. Journal of the Indian Medical Association 2009;107:598-601.

J Fernandez, A Hobson, S Talwar & P O'Kane. Excimer Laser Atherectomy: A novel strategy to aid management of stent underexpansion. Eurointervention 2011; 7(3): 400-407.

J Fernandez, A Hobson, D McKenzie, S Talwar & P O'Kane. Treatment of calcific coronary artery stenosis with the use of excimer laser coronary therectomy and rotational atherectomy. Interventional Cardiology October 2010 2(6) 801-806.

How should I treat severe calcific coronary artery disease? Fernandez JP, Hobson AR, McKenzie DB, Talwar S, O'Kane PD. EuroIntervention. 2011 Jul;7(3):400-7.

How should I treat severe coronary artery calcification when it is not possible to dilate a balloon or deliver a RotaWire™? McKenzie DB, Talwar S, Jokhi PP, O'Kane PD, Osherov A, Strauss B, Dahm J. EuroIntervention. 2011 Jan;6(6):779-83.

Zeb M1, McKenzie DB, Scott PA, Talwar S. Treatment of coronary aneurysms with covered stents: a review with illustrated case. J Invasive Cardiol. 2012 Sep;24(9):465-9. Review

Rana O, Moran R, O'Kane P, Boyd S, Swallow R, Talwar S, Levy T. PCI in the very elderly (>85 years): trends and outcomes. Br J Cardiol 2013;20:27-31

Fernandez JP1, Hobson AR, McKenzie D, Shah N, Sinha MK, Wells TA, Levy TM, Swallow RA, Talwar S, O'Kane PD. Beyond the balloon: excimer coronary laser atherectomy used alone or in combination with rotational atherectomy in the treatment of chronic total occlusions, non-crossable and non-expansible coronary lesions. EuroIntervention. 2013 Jun 22;9(2):243-50.

Fernandez JP1, Hobson AR, McKenzie D, Shah N, Sinha MK, Wells TA, Levy TM, Swallow RA, Talwar S, O'Kane PD. Beyond the balloon: excimer coronary laser atherectomy used alone or in combination with rotational atherectomy in the treatment of chronic total occlusions, non-crossable and non-expansible coronary lesions. EuroIntervention. 2013 Jun 22;9(2):243-50.

Cardiovasc Revasc Med. 2014 Jan;15(1):29-34. Optical coherence tomography following percutaneous coronary intervention with Excimer laser coronary atherectomy. Rawlins J1, Talwar S2, Green M2, O'Kane P3

Curr Cardiol Rev. 2014 Mar 31. [Epub ahead of print] Adjunctive Strategies in the Management of Resistant, 'Undilatable' Coronary Lesions After Successfully Crossing a CTO with a Guidewire. Fairley SL, Spratt JC, Rana O, Talwar S, Hanratty CG, Walsh SJ1

Fairley SL, Spratt JC, Rana O, Talwar S, Hanratty C, Walsh S1. Adjunctive strategies in the management of resistant, 'undilatable' coronary lesions after successfully crossing a CTO with a guidewire. Curr Cardiol Rev. 2014 May;10(2):145-57

Rawlins J, Talwar S, Green M, O'Kane P. Optical coherence tomography following percutaneous coronary intervention with Excimer laser coronary atherectomy. Cardiovasc Revasc Med. 2014 Jan;15(1):29-34

Sharma V, Jadhav ST, Harcombe AA, Kelly PA, Mozid A, Bagnall A, Richardson J, Egred M, McEntegart M, Shaukat A, Oldroyd K, Vishwanathan G, Rana O, Talwar S, McPherson M, Strange JW, Hanratty CG, Walsh SJ, Spratt JC, Smith WH. Impact of proctoring on success rates for percutaneous revascularisation of coronary chronic total occlusions. Open Heart. 2015 Mar 28;2(1):e000228

Viswanathan GN1,2, Din JN1, Swallow RA1, Levy TM1, Boyd S1, Talwar S1, O'Kane PD1. Feasibility and Efficacy of Herculink Elite ((TM)) Biliary Stent Implantation in Large Coronary Arteries (≥ 5 mm) and Venous Conduits: An Observational Study. J Interv Cardiol. 2015 Aug;28(4):374-9.

Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. Gershlick AH, Khan JN, Kelly DJ, Greenwood JP, Sasikaran T, Curzen N, Blackman DJ, Dalby M, Fairbrother KL, Banya W, Wang D, Flather M, Hetherington SL, Kelion AD, Talwar S, Gunning M, Hall R, Swanton H, McCann GP. J Am Coll Cardiol. 2015 Mar 17;65(10):963-72

Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk. Philip Urban, M.D., Ian T. Meredith, M.B., B.S., Ph.D., Alexandre Abizaid, M.D., Ph.D., Stuart J. Pocock, Ph.D., Didier Carrié, M.D., Ph.D., Christoph Naber, M.D., Ph.D., Janusz Lipiecki, M.D., Ph.D., Gert Richardt, M.D., Andres Iñiguez, M.D., Ph.D., Philippe Brunel, M.D., Mariano Valdes-Chavarri, M.D., Ph.D., Philippe Garot, M.D., Suneel Talwar, M.B., B.S., M.D., Jacques Berland, M.D., Mohamed Abdellaoui, M.D., Franz Eberli, M.D., Keith Oldroyd, M.B., Ch.B., M.D., Robaayah Zambahari, M.B., B.S., M.D., John Gregson, Ph.D., Samantha Greene, B.A., Hans-Peter Stoll, M.D., and Marie-Claude Morice, M.D. for the LEADERS FREE Investigators. N Engl J Med 2015; 373:2038-2047

Talwar S, Khan K. A case report of Myocardial Infarction presenting in Hypertrophic Cardiomyopathy. British Journal of Cardiology 2002; 9: 120-121.

Talwar S, Maxwell S. Aspirin therapy in diabetic subjects post-myocardial infarction. Eur Heart J. 1997; 18: 1836.

Khan KM, Talwar S. Screening for familial hypertrophic cardomyopathy using brain natriuretic peptide. Eur Heart J. 1999; 20(7): 550.

Talwar S, Downie PF. Left ventricular dysfunction among elderly patients in general practice. Electrocardiograms are useful in these patients. BMJ 1999; 318 (7196): 1483.

Pulikal GA, Cox ID, Talwar S. Images in cardiovascular medicine. Radial arteriovenous fistula after cardiac catheterization. Circulation. 2005 Feb 15;111(6):e 99.

Brachial artery perforation repaired with Percutaneous transfemoral covered stent deployment in a patient on abciximab. D Kelly & S Talwar. Journal of Invasive Cardiology (In press)

Adjunctive use of Excimer Laser Catheter Atherectomy (ECLA) during PCI in a 26 year old saphenous vein graft. Sinha MK and Talwar S. Accepted TCTMD on line case reports Sep 2007

Use of laser atherectomy and IVUS guidance during PCI on a saphenous vein bypass graft with subtotal occlusion. Percy Johki, Suneel Talwar and Peter O’Kane. Journal of EuroIntervention Nov 2008 volume 4 (3).

Jokhi P, McKenzie DB, Talwar S. Use of a novel pericardial covered stent to treat an iatrogenic coronary perforation. J Invasive Cardiol (2009) In press

McKenzie DB, Talwar S, Jokhi PP, O’Kane PD. How should I treat coronary artery calcification when it is not possible to dilate a balloon or deliver a Rota Wire. EuroIntervention (2011); 6(6): 779-783

Shah B, Talwar S, Rozkovec A. Emergency bailout balloon aortic valvuloplasty following diagnostic cardiac catherisation in a patient with severe valvular aortic stenosis and severe coronary artery disease. The International Journal of Cardiology 2010, Voume 8, number 1.

Jokhi P, Talwar S, O’Kane P. Use of laser atherectomy and IVUS guidance during PCI on a saphenous vein bypass graft with subtotal occlusion. Eurointervention 2008;4 (Web)

How to untie a transfemoral catheter knot. J Rawlings, N Shah, S Talwar & P O'Kane. Br J Cardiol 2013 (20).

S Talwar, I Squire, DB Barnett, JE Davies, L Ng. N-terminal proBNP predicts left ventricular wall motion index in an unselected population. (oral presentation and poster, British Cardiac Society, Manchester 1999). Heart (S1) 1999:81: 7

S Talwar, IB Squire, JE Davies, DB Barnett, LLNg. Cardiotrophin-1 : A newly identified cytokine is present in normal human plasma and increased in heart failure. (oral presentation, British Cardiac Society, Manchester 1999). Heart (S1) 1999:81: 8

S Talwar, IB Squire, JE Davies, DB Barnett, LL Ng. Plasma Cardiotrophin-1 levels following MI and the relationship with ventricular dysfunction. (oral presentation and poster, British Cardiac Society, Manchester 1999). Heart (S1) 1999:81: 37

A Siebenhofer, S Talwar, B Williams, LL Ng. Plasma CT-1 is elevated in hypertensive patients. (oral presentation at the 9th European meeting on Hypertension, Milan, 1999). Journal of hypertension (Suppli.3) 1999; 17: S149

S Talwar, PF Downie, IB Squire, J Davies, DB Barnett, LL Ng. The effect of valvular regurgitation on plasma Cardiotrophin-1in patients with normal left ventricular systolic function. (oral presentation at the Heart Failure ’99, Sweden). European Journal of Heart Failure 1999(Suppl 1); 1:7

S Talwar, I Squire, JE Davies, DB Barnett ,LL Ng. Biochemical detection of left ventricular dysfunction following acute myocardial infarction using plasma N-Terminal proBNP. (poster presentation at the Heart Failure’99, Sweden). European Journal of Heart Failure 1999(Suppl 1); 1:32-33

S Talwar, D Hughes, I Squire, JE Davies, DB Barnett, LL Ng. A novel non-radioactive immunoluminometric assay for N-terminal proBrain Natriuretic Peptide: A test for left ventricular dysfunction. (poster presentation at the Heart Failure ’99, Sweden). European Journal of Heart Failure 1999(Suppl 1); 1:43

S Talwar, I Squire, JE Davies, DB Barnett ,LL Ng. Biochemical detection of left ventricular dysfunction following acute myocardial infarction using plasma N-Terminal proBNP. (poster presentation at the Heart Failure’99, Sweden). European Journal of Heart Failure 1999(Suppl 1); 1:32-33

S Talwar, D Hughes, I Squire, JE Davies, DB Barnett, LL Ng. A novel non-radioactive immunoluminometric assay for N-terminal proBrain Natriuretic Peptide: A test for left ventricular dysfunction. (poster presentation at the Heart Failure ’99, Sweden). European Journal of Heart Failure 1999(Suppl 1); 1:43

S Talwar, I Squire, JE Davies, DB Barnett ,LL Ng. Biochemical detection of left ventricular dysfunction following acute myocardial infarction using plasma N-Terminal proBNP. (poster presentation at the Heart Failure’99, Sweden). European Journal of Heart Failure 1999(Suppl 1); 1:32-33

S Talwar, D Hughes, I Squire, JE Davies, DB Barnett, LL Ng. A novel non-radioactive immunoluminometric assay for N-terminal proBrain Natriuretic Peptide: A test for left ventricular dysfunction. (poster presentation at the Heart Failure ’99, Sweden). European Journal of Heart Failure 1999(Suppl 1); 1:43

S Talwar, PF Downie, I Squire, JE Davies, DB Barnett, LLNg. Cardiotrophin-1: A newly identified cytokine is present in normal human plasma and increased in heart failure. (poster presentation at the Heart Failure ’99, Sweden). European Journal of Heart Failure 1999(Suppl 1); 1:43

S Talwar, IB Squire, JE Davies, DB Barnett, LL Ng. A comparison of a rapid assessment of ejection fraction by acoustic quantification with wall motion index after myocardial infarction. (poster presentation at the Heart Failure ’99, Sweden). European Journal of Heart Failure 1999(Suppl 1); 1:43

RK Pathmanathan, S Talwar, EW LaU, J Cooper, JD Skehan, PJ Stafford, MJ Griffith. Pre-excited atrial fibrillation- A fresh approach to ECG diagnosis. (oral presentation at the World congress for Electrophysiology and Pacing, Berlin 1999).

RK Pathmanathan, S Talwar, EW LaU, J Cooper, JD Skehan, PJ Stafford, MJ Griffith. Pre-excited atrial fibrillation- A fresh approach to ECG diagnosis. (poster presentation at the XXIst Congress of the European Society of Cardiology, Spain 1999). European Heart Journal (S) 1999; 20: 576

S Talwar, I Squire, JE Davies, DB Barnett ,L Ng.N-Terminal proBNP as a marker of left ventricular dysfunction: The influence of heart failure treatment. (oral presentation at the XXIst Congress of the European Society of Cardiology, Spain 1999). European Heart Journal (S) 1999; 20: 256

S Talwar, PF Downie, I Squire, JE Davies, DB Barnett, LLNg. Elevated plasma Cardiotrophin-1 in patients with left ventricular systolic dysfunction. (oral presentation at the XXIst Congress of the European Society of Cardiology, Spain 1999). European Heart Journal (S) 1999; 20: 256

S Talwar, PF Downie, IB Squire, JE Davies, DB Barnett, LL Ng. Plasma N-Terminal pro BNP and Cardiotrophin-1 in aortic stenosis. (poster presentation at the XXIst Congress of the European Society of Cardiology, Spain 1999). European Heart Journal (S) 1999; 20:557

S Talwar, A Siebenhofer, B Williams, LL Ng. Influence of hypertension, left ventricular hypertrophy & left ventricular systolic dysfunction on plasma Cardiotrophin-1 levels. (poster presentation at the XXIst Congress of the European Society of Cardiology, Spain 1999). European Heart Journal (S) 1999; 20: 84

S Talwar, PF Downie, IB Squire, JE Davies, DB Barnett, LL Ng Increased Plasma CT-1 following an acute myocardial infarction and its relationship to left ventricular systolic dysfunction. (oral presentation at the XXIst Congress of the European Society of Cardiology, Spain 1999). European Heart Journal (S) 1999; 20:242

S Talwar, A Siebenhofer, B Williams, LL Ng. Influence of hypertension, left ventricular hypertrophy & left ventricular systolic dysfunction on plasma Cardiotrophin-1 levels. (Poster presentation at the American Heart Association, Atlanta 1999). Circulation (S) 1999; I604.

S Talwar, I Squire, DB Barnett, JE Davies, LL Ng. Biochemical assessment of left ventricular systolic function in an unselected echo population using N-Terminal proBNP. (Oral presentation at the American Heart Association, Atlanta 1999). Circulation (S) 1999; 18: I362-I363.

S Talwar, Squire IB, Downie PF, O’Brien RJ, McCullough AM, Campton MC, Davies JE, Barnett DB, Ng L.L. Plasma CT-1 Following AMI And Its Relationship To Left Ventricular Systolic Dysfunction. (oral presentation and poster, British Cardiac Society, Glasgow 2000). Heart (S) 2000; 83(S1):55.

S Talwar, I Squire, JE Davies, DB Barnett ,L Ng. Optimum time of measurement of NTproBNP for identification of patients with HF following an AMI. (oral presentation and poster, British Cardiac Society, Glasgow 2000). Heart (S) 2000; 83(S1):59.

S Talwar, PF Downie, IB Squire, JE Davies, DB Barnett, LL Ng. Plasma Cardiotrophin-1 and the N-Terminal of pro-Brain Natriuretic Peptide are elevated in Braunwald class IIIB unstable angina. (oral presentation and poster, British Cardiac Society, Glasgow 2000). Heart (S) 2000; 83(S1):46.

S Talwar, IB Squire, PF Downie, RJ O’Brien, JE Davies, LL Ng. Elevated circulating cardiotrophin-1 in heart failure: relationship with parameters of left ventricular systolic dysfunction. (poster presentation at the XXI1nd Congress of the European Society of Cardiology, Amsterdam 2000). European Heart Journal (S) 2000: 21 :662

S Ghosh, LL Ng, S Talwar, IB Squire, M Galinanes. Cardiotrophin-1 protects human myocardium from ischaemic injury: comparison with cardioprotection by ischaemic preconditioning. (poster presentation at the XXI1nd Congress of the European Society of Cardiology, Amsterdam 2000). European Heart Journal (S) 2000; 21: 80

S Talwar, GA Haywood. Long Waiting lists for Coronary Angioplasty: Do they lead to increased adverse events? (oral presentation and poster, British Cardiac Society, Glasgow 2000). Heart (S) 2000; 83(S1): 4.

LE Coats, S Talwar, GM Hughes, PM Gent, JG Motwani, CJ Burrell, GA Haywood. Role of the electrocardiogram in identifying left ventricular systolic impairment in a high risk population. (Accepted for poster presentation at the Heart Failure ’2001, Barcelona). European Journal of Heart Failure 2001(Suppl): In press.

S Talwar, CJ Burrell, JG Motwani, TJ Gilbert, GA Haywood. Long Waiting lists for Coronary Angioplasty: Do they lead to increased adverse events? Oral presentation at the 4th International meeting on Interventional cardiology: Frontiers in Interventional cardiology, London. Int J of Cardiovascular Interventions 2001; 4 (Supp 1): 11.

S Talwar et al. Findings at femoral angiography prior to Angio-Seal hemostatic femoral puncture device deployment-predictors of failure. Oral presentation at the 4th International meeting on Interventional cardiology: Frontiers in Interventional cardiology, London. Int J of Cardiovascular Interventions 2001; 4 (Supp 1): 22.

K Jacob, S Talwar, A Copplestone, T G Gilbert, G A Haywood. Plasma Fibrinogen, Antithrombin III, Protein C and D-dimers in patients with chronic atrial fibrillation: Effects of electrical cardioversion in the short and medium term. (Accepted for poster presentation at the XXIIIrd Congress of the ESC, Stockholm 2001). European Heart Journal (S) 2001, 22: 557.

RJ O’Brien, IB Squire, S Talwar, JE Davies, LL Ng. Correlation of plasma n-BNP and Cardiotrophin-1 levels after myocardial infarction. (Accepted for poster presentation at the XXIIIrd Congress of the European Society of Cardiology, Stockholm 2001). European Heart Journal (S) 2001, 22: 396.

K Jacob, S Talwar, A Copplestone, T G Gilbert, G A Haywood. Plasma Fibrinogen, Antithrombin III, Protein C and D-dimers in patients with chronic atrial fibrillation: Effects of electrical cardioversion in the short and medium term. (Accepted for Poster presentation at the AHA, Anaheim, California 2001). Circulation (S) 2001; In press.

Diane Defriend, Julian Elford, S Talwar, Carl Roobottom. The usefulness of femoral angiography prior to deployment of the Angio-Seal percutaneous closure device . Oral presentation at the Annual Meeting of the British Society of Interventional Radiology, Cardiff, UK. (November 2001).

S Talwar, C Vorwerk, CJ Burrell, JG Motwani, GA Haywood. What is the adverse coronary event rate of patients awaiting a PCI? An 18 month longitudinal study. (Accepted for poster presentation at the XXIVth Congress of the European Society of Cardiology, Berlin 2002). European Heart Journal (S) 2002 In press.

S Talwar, LDR Smith, SJ Evans, IH Mahy, JG Motwani, CJ Burrell. Coronary Revascularisation in the South-west of England: Conversion Rates for Coronary Angiography. Abstract accepted for presentation to the BCS 2003. Heart 2003; 89(Suppl 1): A17.

Novel treatment of Clopidogrel Intolerence. U rao, S Talwar & R Swallow. Poster presentation at the British Cardiovascular Annual Conference, Manchester 2-4 June 2008. Published in Heart Suppl 2008, Abstract number 248.

The use of Excimer Coronary Atherectomy for balloon failures during PCI. Hobson AR, Fernandez JP, Mckenzie D, Jokhi P, Sinha M, Wells T, Swallow R, Levy T, O’Kane P, Talwar S. Presentation at Euro PCR, Paris 2010.

J Fernandez, Al Sahli, Hobson AR, McKenzie DB, Wells TA, Sinha MK, R Swallow, T Levy, S talwar, P O’Kane. How safe and efficacious is PCI for unprotected Left Main Stem Disease in a high volume non-surgical centre. Accepted for oral presentation at EuroPCR 2011 (Oral presentation)

J Fernandez, Al Sahli, Hobson AR, McKenzie DB, Wells TA, Sinha MK, R Swallow, T Levy, S talwar, P O’Kane. How safe and efficacious is PCI for unprotected Left Main Stem Disease in a high volume non-surgical centre. Accepted for oral presentation at world congress of cardiology, Dubai 2012 (Oral presentation)

Willington R, Al Sahli, O’Kane P, Talwar S, Levy T. Two year survival post PCI with and without Intravascular Ultrasound: Implications for patients with high risk coronary artery disease. Accepted for poster presentation at Euro PCR 2011.

P Rees, J Fernandez, R Swallow, T Levy, S talwar, P O’Kane. Safety and efficacy of PCI for unprotected Left Main Stem Disease in a high volume non-surgical centre. Accepted for oral presentation at World Congress of Cardiology, Dubai (Oral presentation)

Mechanism of drug eluting stent restenosis and the importance of intravascular ultrasound in guiding repeat coronary interventions. Accepted for Presentation at Euro PCR 2011.

Shah B, Talwar S, Rozkovec A. Emergency balloon aortic valvuloplasty to treat refractory cardiogenic shock following diagnostic cardiac catherisation in a patient with severe valvular aortic stenosis and severe coronary artery disease. Presentation at ESC congress 2011.

Poster presentation at TCT 2013 San Francisco: Early UK experience of the AXXES dedicated bifurcation experience.

Presentation at Euro PCR Paris 2013 on Combination of techniques in treating complex lesion during STEMI.

Presentation at Euro PCR Paris 2013 on successful use of Impella, Laser and Rotational Atherectomy on high risk complex PCI.

Presentation at World Congress of Cardiology, Melbourne May 2014 on Treatment of Under-Expanded coronary stents with Excimer Coronary Laser Atherectomy.

Presentation at World Congress of Cardiology, Melbourne May 2014 on procedural successes and clinical outcomes of Tryton dedicated bifurcation stent deployment with drug eluting stents in side branch in an unselected population: findings from a single centre registry.

Presentation at TCT 2013 (San Francisco) on treatment of chronic total occlusion of right coronary artery using an occluded venous graft: a novel reverse cart approach using 3 guiding catheters in antive vessels and a venous graft.

Presentation at TCT 2013 (San Francisco) on coronary intervention of native obtuse marginal artery via venous graft to first diagonal artery.

Presentation at TCT 2013 (San Francisco) on treatment of chronic total occlusion of right coronary artery using an occluded venous graft: a novel reverse cart approach using 3 guiding catheters in antive vessels and a venous graft.

Presentation at TCT 2013 (San Francisco) on coronary intervention of native obtuse marginal artery via venous graft to first diagonal artery.

Presentation at Euro PCR 2014 (Paris) on Laser, OCT and bio absorbable stent in a young patient with STEMI and large thrombus burden

Presentation at Euro PCR 2014 (Paris) on retreival of a stalled burr during rotational atherectomy.

Presentation at Euro PCR 2014 (Paris) on successful use of biliary stents during PCIs in patients with large calibre coronary arteries and venous conduits.

Presentation at India Live 2014: Early UK experience of the AXXESS bifurcation stent.

Presentation at Euro PCR 2014 (Paris) on exertional angina with angiographically mild mid LAD atheroma: epicardial disease, microvacular disease, or both.

Presentation at Euro PCR 2014 (Paris) on PPCI for Inferior STEMI during redo atrial fibrillation ablation.

Presentation at AHA 2014 (Chicago) on does gender influence chronic total occlusion PCI outcome?

Presentation at C3 conference 2104 (Orlando) on severe angiographically documented coronary artery spasm in a pilot induced in the cath lab with cold water.

Rana O, Talwar S, O'Kane P. Excimer coronary laser atherectomy during PCIs of complex lesions: balloon failures, chronic total occlusions and under exapnded stents. Laser in cardiovascular medicine (Book chapter) Springer 2014.

Presentation at C3 conference 2104 (Orlando) on pressure wire assessment of an artery supplying non-viable myocardium.

Presentation at TCT 2014 (Washington, DC.) on primary PCI and stenting on a thin filament of uncoiled BMW wire.

Presentation at TCT 2014 (Washington, DC.) on contemporary PC? Overlapping bioabsorbable scaffold, AXXESS bifurcation stent and drug eluting stent.

Presentation at TCT 2014 (Washington, DC.) on worlds first series left main bifurcation treated with the AXXESS bifurcation 4.0x9 didicated bifucation stent.

Kodoth V, Talwar S, Din JN, Levy T, Swallow R, O’Kane P. Contemporary DES for high risk bleeding patients: Real world experience of the polymer-free Biofreedom stent. Abstract accepted at TCT 2015